Histopathological and clinical changes in patients with severe lupus nephritis treated with rituximab plus cyclophosphamide: A rebiopsy study in 7 patients

被引：0
|
作者：
Gunnarsson, I.
Sundelin, B.
Jonsdottir, T.
Jacobsson, S. H.
Welin-Henriksson, E.
Van Vollenhoven, R. F.
机构：
[1] Karolinska Univ Hosp, Stockholm, Sweden
[2] Danderyd Hosp, Stockholm, Sweden
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2006年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：64 / 64
页数：1
相关论文
共 50 条
  • [1] Histopathological and clinical changes in 7 patients with severe proliferative lupus nephritis treated with rituximab plus cyclophosphamide: A rebiopsy study.
    Gunnarsson, Iva
    Sundelin, Birgitta
    Jonsdottir, Thorunn
    Jacobsson, Stefan H.
    Welin-Henriksson, Elisabet
    Van Vollenhoven, Ronald F.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S823 - S823
  • [2] Histopathological and clinical response in proliferative lupus nephritis patients treated with rituximab
    Gunnarsson, Iva
    Jonsdottir, Thorunn
    Sundelin, Birgitta
    Jacobson, Stefan
    van Vollenhoven, Ronald
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2006, 35 : 11 - 12
  • [3] A Retrospective Observational Study of Patients with Lupus Nephritis Treated with Rituximab in Combination with Cyclophosphamide
    Oliveira, Nidia
    Ibanez, Monica
    Ciang, Natalia
    Isenberg, David A.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [4] Long-term renal outcome in rituximab-treated patients with lupus nephritis:: A biopsy/rebiopsy study
    Jonsdottir, Thorunn
    van Vollenhoven, Ronald F.
    Zickert, Agneta
    Henriksson, Bisabeth Welin
    Sundelin, Birgitta
    Gunnarsson, Iva
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S924 - S924
  • [5] EFFICACY OF MYCOPHENOLATE MOFETIL PLUS RITUXIMAB COMPARED WITH INTRAVENOUS CYCLOPHOSPHAMIDE PLUS RITUXIMAB IN PATIENTS WITH RELAPSING LUPUS NEPHRITIS
    Fajardo Hermosillo, L. D.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1169 - 1169
  • [6] Serological changes in patients with severe SLE treated with rituximab and cyclophosphamide
    Jonsdottir, Porunn
    Gunnarsson, Iva
    Risselada, Anke
    Wallerskog, Therese
    Welin-Henriksson, Elisabeth
    Winqvist, Ola
    Wikstrom, Charlotte
    Klareskog, Lars
    van Vollenhoven, Ronald F.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2006, 35 : 26 - 27
  • [7] Serological changes in patients with severe SLE treated with rituximab and cyclophosphamide.
    Jónsdóttir, Thórunn
    Gunnarsson, Iva
    Risselada, Anke
    Wallerskog, Therese
    Winqvist, Ola
    Wikström, Ann-Charlotte
    Klareskog, Lars
    van Vollenhoven, Ronald F.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S259 - S260
  • [8] Long-term follow-up in lupus nephritis patients treated with rituximab-clinical and histopathological response
    Jonsdottir, Thorunn
    Zickert, Agneta
    Sundelin, Birgitta
    Henriksson, Elisabet W.
    van Vollenhoven, Ronald F.
    Gunnarsson, Iva
    RHEUMATOLOGY, 2013, 52 (05) : 847 - 855
  • [9] Renal Histopathological Changes and Clinical Characteristics of Antiphospholipid Nephropathy in Lupus Nephritis Patients
    Kotb, Hanan
    Mokbel, Abir
    El Maghraby, Ahmed
    Fadda, Sawsan
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1183 - 1183
  • [10] Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis
    Gunnarsson, Iva
    Sundelin, Birgitta
    Jonsdottir, Thorunn
    Jacobson, Stefan H.
    Henriksson, Elisabet Welin
    van Vollenhoven, Ronald F.
    ARTHRITIS AND RHEUMATISM, 2007, 56 (04): : 1263 - 1272
12345